Volume: 43 Issue: 1
Year: 2023, Page: 335-340, Doi: https://doi.org/10.51248/.v43i01.2082
Introduction and Aim: Various biochemical and hematological variables are important for predicting the progression of diabetes to diabetic complications, analyzing health-economic status, and examining the effectiveness of antidiabetic agents. The aim of this study is to find the association between clinical variables and type 2 diabetes, diabetic nephropathy and cardiovascular disease.
Materials and Methods: A total of 300 participants’ details were studied and divided into 3 groups; type 2 diabetes (n=100), diabetic nephropathy (n=100), and cardiovascular disease (n=100). Various biochemical and hematological variable data were collected from the patient file. BUN and inflammatory markers such as NLR, PLR, LMR and SII were calculated. P value ≤ 0.05 is statistically significant.
Results: A comparison of biochemical data, such as HbA1c, urea, creatinine, and sodium, revealed statistically significant differences between the three groups. Hematological parameters, such as RBC, Hb, WBC, PCT, and RDW, were also found to be significant. We calculated BUN, BCR, NLR, PLR, LMR, and SII and found they were significant.
Conclusion: Clinical variables along with HbA1c as one of the most significant predictors can help define a person's risk profile for type 2 diabetes and the progression of diabetic complications. It may offer a new challenge to health education and therapeutic interventions designed to prevent diabetic complications
Keywords: Type 2 diabetes mellitus; diabetic complication; clinical variables
1. Oberoi, S., Kansra, P. Economic menace of diabetes in India: a systematic review. Int J Diabetes Dev Ctries. 2020;40: 464-475.
2. Mauricio, D., Alonso, N., Gratacòs, M. Chronic diabetes complications: the need to move beyond classical concepts. Trends Endocrinol Metab. 2020;31(4): 287-295.
3. Lascar, N., Brown, J., Pattison, H., Barnett, A.H., Bailey, C.J., Bellary, S., et al., Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69-80.
4. Buyadaa, O., Salim, A., Morton, J.I., Magliano, D.J., Shaw, J.E. Rate of decline in kidney function and known age-of-onset or duration of type 2 diabetes. Sci Rep. 2021;11(1):1-8.
5. Gkrania-Klotsas, E., Ye, Z., Cooper, A.J., Sharp, S.J., Luben, R., Biggs, M.L., et al., Differential White Blood Cell Count and Type 2 Diabetes: Systematic Review and Meta-Analysis of Cross-Sectional and Prospective Studies. PLOS ONE. 2010;5(10):e13405. https://doi.org/10.1371/journal.pone.0013405
6. Biadgo, B., Melku, M., Abebe, S.M., Abebe, M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016; 9:91-99.
7. Moradi, S., Kerman, R.J., Rohani, F., Salari, F. Association between diabetes complications and leukocyte counts in Iranian patients. J Inflamm Res. 2012;5(1):7-11.
8. Mallik, R., Chowdhury, T. A. Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future. Ther Adv Endocrinol Metab. 2022; 13:1-19.
9. Artha, I.M., Bhargah, A., Dharmawan, N.K., Pande, U.W., Triyana, K.A., Maharishi, P.A., et al., High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag. 2019; 15:149-157.
10. Nair, A., Jayakumari, C., Jabbar, P.K., Jayakumar, R. V., Raizada, N., Gopi, A., et al., Prevalence and Associations of Hypothyroidism in Indian Patients with Type 2 Diabetes Mellitus. J. Thyroid Res. 2018. https://doi.org/10.1155/2018/5386129
11. Demitrost, L., Ranabir, S. Thyroid dysfunction in type 2 diabetes mellitus: A retrospective study. Indian J Endocrinol Metab. 2012;16(2): S334-S335.
12. Akalu, Y., Belsti, Y. Hypertension and its associated factors among type 2 diabetes mellitus patients at Debre Tabor general hospital, northwest Ethiopia. Diabetes Metab Syndr Obes. 2020; 13:1621-1631.
13. Okosun, I.S., Chandra, K.D., Choi, S., Christman, J., Dever, G.A., Prewitt, T.E., et al., Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res. 2001;9(1):1-9.
14. Liu, F., Ma, G., Tong, C., Zhang, S., Yang, X., Xu, C., et al., Elevated blood urea nitrogen-to-creatinine ratio increased the risk of coronary artery disease in patients living with type 2 diabetes mellitus. BMC Endocr Disord. 2022;22(1):1-10.
15. Unnikrishnan, A.G., Sahay, R.K., Phadke, U., Sharma, S.K., Shah, P., Shukla, R., et al., Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. PloS One. 2022;17(3):e0263619. https://doi.org/10.1371/journal.pone.0263619
16. Bora, K., Borah, M., Chutia, H., Nath, C.K., Das, D., Ruram, A. A., et al., Presence of Concurrent Derangements of Liver
Function Tests in Type 2 Diabetes and Their Relationship with Glycemic Status: A Retrospective Observational Study from Meghalaya. J lab Physicians. 2016;8(1):30-35.
17. Wang, Z.S., Song, Z.C., Bai, J.H., Li, F., Wu, T., Qi, J., et al., Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus. Vasc Health Risk Manag. 2013; 9:237-243.
18. Biadgo, B., Melku, M., Abebe, S.M., Abebe, M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016; 9:91-99.
19. Khan, H.A., Ola, M.S., Alhomida, A.S., Sobki, S.H., Khan, S.A. Evaluation of HbA1c criteria for diagnosis of diabetes mellitus: a retrospective study of 12 785 type 2 Saudi male patients. Endocr Res. 2014;39(2):62-66.
20. Su, J.B., Zhao, L.H., Zhang, X.L., Cai, H.L., Huang, H.Y., Xu, F., et al., HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2018;17(1):1-9.
21. Lou, M., Luo, P., Tang, R., Peng, Y., Yu, S., Huang, W., et al., Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15(1):1-6.
22. Rahar, S., Marwah, S., Kulshreshtha, B. Neutrophil lymphocyte ratio (NLR) in type 2 diabetes mellitus and its correlation with renal function: An institutional experience. Journal of Dr. NTR University of Health Sciences. 2021;10(2):82.
23. Xu, T., Weng, Z., Pei, C., Yu, S., Chen, Y., Guo, W., et al., The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus. Medicine (Baltimore). 2017; 96(45): e8289. https://doi.org/10.1097%2FMD.0000000000008289
24. Yu, L., Yang, H., Yuan, H. Predictive value of peripheral blood platelet to lymphocyte ratio for the survival in elderly patients with diabetic ketoacidosis. Chinese Journal of Geriatrics. 2020:1186-1190.
25. Urbanowicz, T., Michalak, M., Al-Imam, A., Rodzki, M., Witkowska, A., Haneya, A.B., et al., The Significance of Systemic Immune-Inflammatory Index for Mortality Prediction in Diabetic Patients Treated with Off-Pump Coronary Artery Bypass Surgery. Diagnostics. 2022;12(3):634.
Renuka Suvarna, Monalisa Biswas, Revathi P. Shenoy, M. Mukhyaprana Prabhu. Association of clinical variables as a predictor marker in type 2 diabetes mellitus and diabetic complications. Biomedicine: 2023; 43(1): 335-340